Francesco Orlando
Overview
Explore the profile of Francesco Orlando including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
164
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Leone G, Orlando F, Dutey-Magni P, Vainauskas O, Grist E, Ciani Y, et al.
JAMA Oncol
. 2025 Feb;
PMID: 40014335
No abstract available.
2.
Fracassi G, Lorenzin F, Orlando F, Gioia U, DAmato G, Casaramona A, et al.
J Clin Invest
. 2024 Dec;
135(4).
PMID: 39718835
PARP inhibitors (PARPi) have received regulatory approval for the treatment of several tumors, including prostate cancer (PCa), and demonstrate remarkable results in the treatment of castration-resistant prostate cancer (CRPC) patients...
3.
Ruiz-Vico M, Wetterskog D, Orlando F, Thakali S, Wingate A, Jayaram A, et al.
Eur Urol Oncol
. 2024 Sep;
8(1):135-144.
PMID: 39261236
Background And Objective: The PRESIDE (NCT02288247) randomized trial demonstrated prolonged progression-free survival (PFS) with continuing enzalutamide beyond progression in metastatic castration-resistant prostate cancer (mCRPC) patients starting docetaxel. This study aims...
4.
Orlando F, Foiani S, Dellavia C, Graziano D, Di Stefano D
Clin Case Rep
. 2024 Apr;
12(4):e8780.
PMID: 38659499
This case report describes the fixed rehabilitation of the lower left arch in a patient following an horizontal GBR procedure by means of a customized titanium mesh and a new...
5.
Franceschini G, Quaini O, Mizuno K, Orlando F, Ciani Y, Ku S, et al.
Cancer Discov
. 2024 Jan;
14(3):424-445.
PMID: 38197680
Significance: Neuroendocrine prostate cancer is an aggressive subtype of treatment-resistant prostate cancer. Early detection is important, but the diagnosis currently relies on metastatic biopsy. We describe the development and validation...
6.
Tironi F, Orlando F, Azzola F, Vitelli C, Francetti L
Int J Periodontics Restorative Dent
. 2023 Jun;
43(5):606-613.
PMID: 37338922
The aim of this retrospective study was to evaluate the performance of implants placed with the All-on-4 technique after a mean time in function of 9 years. A total of...
7.
Di Stefano D, Orlando F, Ottobelli M, Fiori D, Garagiola U
Maxillofac Plast Reconstr Surg
. 2022 Jul;
44(1):24.
PMID: 35821286
After tooth extraction, dimensional changes affect the alveolar socket, leading to loss in alveolar bone height and width. Histological modifications also occur, with initial formation of a blood clot that...
8.
Melandro F, Basta G, Torri F, Biancofiore G, Del Turco S, Orlando F, et al.
Artif Organs
. 2022 Jun;
46(9):1727-1740.
PMID: 35733227
Background: Organs from donation after circulatory death (DCD) are increasingly used for liver transplantation, due to the persisting organ shortage and waiting list mortality. However, the use of DCD grafts...
9.
Jeddou H, Tzedakis S, Orlando F, Robert A, Meneyrol E, Bergeat D, et al.
Cancers (Basel)
. 2022 Jun;
14(11).
PMID: 35681768
How the side of an extended liver resection impacts the postoperative prognosis of advanced perihilar cholangiocarcinoma (PHC) is still controversial. We compared the outcomes of right (RTS) and left trisectionectomies...
10.
Orlando F, Romanel A, Trujillo B, Sigouros M, Wetterskog D, Quaini O, et al.
NAR Cancer
. 2022 Jun;
4(2):zcac016.
PMID: 35664542
Sequencing of cell-free DNA (cfDNA) in cancer patients' plasma offers a minimally-invasive solution to detect tumor cell genomic alterations to aid real-time clinical decision-making. The reliability of copy number detection...